Loading…
Characterizing Discrete Subsets of Polycystic Ovary Syndrome as Defined by the Rotterdam Criteria: The Impact of Weight on Phenotype and Metabolic Features
Context: The Rotterdam criteria for polycystic ovary syndrome (PCOS) defines discrete subgroups whose phenotypes are not yet clear. Objective: The phenotypic characteristics of women in the PCOS subgroups defined by the Rotterdam criteria were compared. Design: The study was observational. Setting:...
Saved in:
Published in: | The journal of clinical endocrinology and metabolism 2006-12, Vol.91 (12), p.4842-4848 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c401t-e3d25736b2baf9660ae8761fd06ce2260d155757677a63ca481c75df217200fa3 |
---|---|
cites | |
container_end_page | 4848 |
container_issue | 12 |
container_start_page | 4842 |
container_title | The journal of clinical endocrinology and metabolism |
container_volume | 91 |
creator | Welt, C. K. Gudmundsson, J. A. Arason, G. Adams, J. Palsdottir, H. Gudlaugsdottir, G. Ingadottir, G. Crowley, W. F. |
description | Context: The Rotterdam criteria for polycystic ovary syndrome (PCOS) defines discrete subgroups whose phenotypes are not yet clear.
Objective: The phenotypic characteristics of women in the PCOS subgroups defined by the Rotterdam criteria were compared.
Design: The study was observational.
Setting: Subjects were studied in an outpatient setting in Boston and Reykjavik.
Patients: Four subgroups of subjects with PCOS defined by 1) irregular menses (IM), hyperandrogenism (HA), and polycystic ovary morphology (PCOM, n = 298); 2) IM/HA (n = 7); 3) HA/PCOM (n = 77); and 4) IM/PCOM (n = 36) and a group of controls (n = 64), aged 18–45 yr, were examined.
Intervention: Subjects underwent a physical exam; fasting blood samples for androgens, gonadotropins, and metabolic parameters; and a transvaginal ultrasound.
Main Outcome Measures: The phenotype was compared between groups.
Results: Ninety-seven percent of women with IM/HA had PCOM. Therefore, the groups with and without PCOM were combined. The Ferriman-Gallwey score and androgen levels were highest in the hyperandrogenic groups (IM/HA and HA/PCOM), whereas ovarian volume was higher in all PCOS subgroups compared with controls, as expected based on the definitions of the PCOS subgroups. Body mass index and insulin levels were highest in the IM/HA subgroup.
Conclusions: Subjects with PCOS defined by IM/HA are the most severely affected women on the basis of androgen levels, ovarian volumes, and insulin levels. Their higher body mass index partially accounts for the increased insulin levels, suggesting that weight gain exacerbates the symptoms of PCOS. |
doi_str_mv | 10.1210/jc.2006-1327 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68224401</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68224401</sourcerecordid><originalsourceid>FETCH-LOGICAL-c401t-e3d25736b2baf9660ae8761fd06ce2260d155757677a63ca481c75df217200fa3</originalsourceid><addsrcrecordid>eNptkc1u1DAYRS1ERYfCjjXyBlak-CexM-yqKYVKrVrRIthZjv2lk1FiB9tBCq_Sl8XRjNRNV7aso3utcxF6R8kpZZR83plTRogoKGfyBVrRdVkVkq7lS7QihNFiLdnvY_Q6xh0htCwr_godU0kIJ3W1Qo-brQ7aJAjdv8494PMumgAJ8N3UREgR-xbf-n42c0ydwTd_dZjx3exs8ANgHfE5tJ0Di5sZpy3gHz7lLKsHvAndkqq_4Pv8fjmMuWVJ-wXdwzbfHL7dgvNpHnOOs_gakm58n0suQKcpQHyDjlrdR3h7OE_Qz4uv95vvxdXNt8vN2VVhSkJTAdyySnLRsEa3ayGIhloK2loiDDAmiKVVJSsppNSCG13W1MjKtozKLK7V_AR93OeOwf-ZICY1ZAvQ99qBn6ISNWNlrsrgpz1ogo8xQKvG0A3ZiKJELWOonVHLGGoZI-PvD7lTM4B9gg_2M_DhAOhodN8G7UwXn7ia5z_zJYjvOXDWm5B9j1lPVDs_BZfNPF__H27dpFY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68224401</pqid></control><display><type>article</type><title>Characterizing Discrete Subsets of Polycystic Ovary Syndrome as Defined by the Rotterdam Criteria: The Impact of Weight on Phenotype and Metabolic Features</title><source>Oxford Journals Online</source><creator>Welt, C. K. ; Gudmundsson, J. A. ; Arason, G. ; Adams, J. ; Palsdottir, H. ; Gudlaugsdottir, G. ; Ingadottir, G. ; Crowley, W. F.</creator><creatorcontrib>Welt, C. K. ; Gudmundsson, J. A. ; Arason, G. ; Adams, J. ; Palsdottir, H. ; Gudlaugsdottir, G. ; Ingadottir, G. ; Crowley, W. F.</creatorcontrib><description>Context: The Rotterdam criteria for polycystic ovary syndrome (PCOS) defines discrete subgroups whose phenotypes are not yet clear.
Objective: The phenotypic characteristics of women in the PCOS subgroups defined by the Rotterdam criteria were compared.
Design: The study was observational.
Setting: Subjects were studied in an outpatient setting in Boston and Reykjavik.
Patients: Four subgroups of subjects with PCOS defined by 1) irregular menses (IM), hyperandrogenism (HA), and polycystic ovary morphology (PCOM, n = 298); 2) IM/HA (n = 7); 3) HA/PCOM (n = 77); and 4) IM/PCOM (n = 36) and a group of controls (n = 64), aged 18–45 yr, were examined.
Intervention: Subjects underwent a physical exam; fasting blood samples for androgens, gonadotropins, and metabolic parameters; and a transvaginal ultrasound.
Main Outcome Measures: The phenotype was compared between groups.
Results: Ninety-seven percent of women with IM/HA had PCOM. Therefore, the groups with and without PCOM were combined. The Ferriman-Gallwey score and androgen levels were highest in the hyperandrogenic groups (IM/HA and HA/PCOM), whereas ovarian volume was higher in all PCOS subgroups compared with controls, as expected based on the definitions of the PCOS subgroups. Body mass index and insulin levels were highest in the IM/HA subgroup.
Conclusions: Subjects with PCOS defined by IM/HA are the most severely affected women on the basis of androgen levels, ovarian volumes, and insulin levels. Their higher body mass index partially accounts for the increased insulin levels, suggesting that weight gain exacerbates the symptoms of PCOS.</description><identifier>ISSN: 0021-972X</identifier><identifier>EISSN: 1945-7197</identifier><identifier>DOI: 10.1210/jc.2006-1327</identifier><identifier>PMID: 17003085</identifier><identifier>CODEN: JCEMAZ</identifier><language>eng</language><publisher>Bethesda, MD: Endocrine Society</publisher><subject>Adolescent ; Adult ; Androgens - blood ; Biological and medical sciences ; Body Mass Index ; Body Weight - physiology ; Endocrinopathies ; Female ; Fundamental and applied biological sciences. Psychology ; Gonadotropins - blood ; Hormones - blood ; Humans ; Medical sciences ; Metabolic Syndrome - blood ; Metabolic Syndrome - epidemiology ; Metabolism - physiology ; Middle Aged ; Phenotype ; Physical Examination ; Polycystic Ovary Syndrome - classification ; Vertebrates: endocrinology</subject><ispartof>The journal of clinical endocrinology and metabolism, 2006-12, Vol.91 (12), p.4842-4848</ispartof><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c401t-e3d25736b2baf9660ae8761fd06ce2260d155757677a63ca481c75df217200fa3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18367737$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17003085$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Welt, C. K.</creatorcontrib><creatorcontrib>Gudmundsson, J. A.</creatorcontrib><creatorcontrib>Arason, G.</creatorcontrib><creatorcontrib>Adams, J.</creatorcontrib><creatorcontrib>Palsdottir, H.</creatorcontrib><creatorcontrib>Gudlaugsdottir, G.</creatorcontrib><creatorcontrib>Ingadottir, G.</creatorcontrib><creatorcontrib>Crowley, W. F.</creatorcontrib><title>Characterizing Discrete Subsets of Polycystic Ovary Syndrome as Defined by the Rotterdam Criteria: The Impact of Weight on Phenotype and Metabolic Features</title><title>The journal of clinical endocrinology and metabolism</title><addtitle>J Clin Endocrinol Metab</addtitle><description>Context: The Rotterdam criteria for polycystic ovary syndrome (PCOS) defines discrete subgroups whose phenotypes are not yet clear.
Objective: The phenotypic characteristics of women in the PCOS subgroups defined by the Rotterdam criteria were compared.
Design: The study was observational.
Setting: Subjects were studied in an outpatient setting in Boston and Reykjavik.
Patients: Four subgroups of subjects with PCOS defined by 1) irregular menses (IM), hyperandrogenism (HA), and polycystic ovary morphology (PCOM, n = 298); 2) IM/HA (n = 7); 3) HA/PCOM (n = 77); and 4) IM/PCOM (n = 36) and a group of controls (n = 64), aged 18–45 yr, were examined.
Intervention: Subjects underwent a physical exam; fasting blood samples for androgens, gonadotropins, and metabolic parameters; and a transvaginal ultrasound.
Main Outcome Measures: The phenotype was compared between groups.
Results: Ninety-seven percent of women with IM/HA had PCOM. Therefore, the groups with and without PCOM were combined. The Ferriman-Gallwey score and androgen levels were highest in the hyperandrogenic groups (IM/HA and HA/PCOM), whereas ovarian volume was higher in all PCOS subgroups compared with controls, as expected based on the definitions of the PCOS subgroups. Body mass index and insulin levels were highest in the IM/HA subgroup.
Conclusions: Subjects with PCOS defined by IM/HA are the most severely affected women on the basis of androgen levels, ovarian volumes, and insulin levels. Their higher body mass index partially accounts for the increased insulin levels, suggesting that weight gain exacerbates the symptoms of PCOS.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Androgens - blood</subject><subject>Biological and medical sciences</subject><subject>Body Mass Index</subject><subject>Body Weight - physiology</subject><subject>Endocrinopathies</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gonadotropins - blood</subject><subject>Hormones - blood</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Metabolic Syndrome - blood</subject><subject>Metabolic Syndrome - epidemiology</subject><subject>Metabolism - physiology</subject><subject>Middle Aged</subject><subject>Phenotype</subject><subject>Physical Examination</subject><subject>Polycystic Ovary Syndrome - classification</subject><subject>Vertebrates: endocrinology</subject><issn>0021-972X</issn><issn>1945-7197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNptkc1u1DAYRS1ERYfCjjXyBlak-CexM-yqKYVKrVrRIthZjv2lk1FiB9tBCq_Sl8XRjNRNV7aso3utcxF6R8kpZZR83plTRogoKGfyBVrRdVkVkq7lS7QihNFiLdnvY_Q6xh0htCwr_godU0kIJ3W1Qo-brQ7aJAjdv8494PMumgAJ8N3UREgR-xbf-n42c0ydwTd_dZjx3exs8ANgHfE5tJ0Di5sZpy3gHz7lLKsHvAndkqq_4Pv8fjmMuWVJ-wXdwzbfHL7dgvNpHnOOs_gakm58n0suQKcpQHyDjlrdR3h7OE_Qz4uv95vvxdXNt8vN2VVhSkJTAdyySnLRsEa3ayGIhloK2loiDDAmiKVVJSsppNSCG13W1MjKtozKLK7V_AR93OeOwf-ZICY1ZAvQ99qBn6ISNWNlrsrgpz1ogo8xQKvG0A3ZiKJELWOonVHLGGoZI-PvD7lTM4B9gg_2M_DhAOhodN8G7UwXn7ia5z_zJYjvOXDWm5B9j1lPVDs_BZfNPF__H27dpFY</recordid><startdate>20061201</startdate><enddate>20061201</enddate><creator>Welt, C. K.</creator><creator>Gudmundsson, J. A.</creator><creator>Arason, G.</creator><creator>Adams, J.</creator><creator>Palsdottir, H.</creator><creator>Gudlaugsdottir, G.</creator><creator>Ingadottir, G.</creator><creator>Crowley, W. F.</creator><general>Endocrine Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20061201</creationdate><title>Characterizing Discrete Subsets of Polycystic Ovary Syndrome as Defined by the Rotterdam Criteria: The Impact of Weight on Phenotype and Metabolic Features</title><author>Welt, C. K. ; Gudmundsson, J. A. ; Arason, G. ; Adams, J. ; Palsdottir, H. ; Gudlaugsdottir, G. ; Ingadottir, G. ; Crowley, W. F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c401t-e3d25736b2baf9660ae8761fd06ce2260d155757677a63ca481c75df217200fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Androgens - blood</topic><topic>Biological and medical sciences</topic><topic>Body Mass Index</topic><topic>Body Weight - physiology</topic><topic>Endocrinopathies</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gonadotropins - blood</topic><topic>Hormones - blood</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Metabolic Syndrome - blood</topic><topic>Metabolic Syndrome - epidemiology</topic><topic>Metabolism - physiology</topic><topic>Middle Aged</topic><topic>Phenotype</topic><topic>Physical Examination</topic><topic>Polycystic Ovary Syndrome - classification</topic><topic>Vertebrates: endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Welt, C. K.</creatorcontrib><creatorcontrib>Gudmundsson, J. A.</creatorcontrib><creatorcontrib>Arason, G.</creatorcontrib><creatorcontrib>Adams, J.</creatorcontrib><creatorcontrib>Palsdottir, H.</creatorcontrib><creatorcontrib>Gudlaugsdottir, G.</creatorcontrib><creatorcontrib>Ingadottir, G.</creatorcontrib><creatorcontrib>Crowley, W. F.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of clinical endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Welt, C. K.</au><au>Gudmundsson, J. A.</au><au>Arason, G.</au><au>Adams, J.</au><au>Palsdottir, H.</au><au>Gudlaugsdottir, G.</au><au>Ingadottir, G.</au><au>Crowley, W. F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterizing Discrete Subsets of Polycystic Ovary Syndrome as Defined by the Rotterdam Criteria: The Impact of Weight on Phenotype and Metabolic Features</atitle><jtitle>The journal of clinical endocrinology and metabolism</jtitle><addtitle>J Clin Endocrinol Metab</addtitle><date>2006-12-01</date><risdate>2006</risdate><volume>91</volume><issue>12</issue><spage>4842</spage><epage>4848</epage><pages>4842-4848</pages><issn>0021-972X</issn><eissn>1945-7197</eissn><coden>JCEMAZ</coden><abstract>Context: The Rotterdam criteria for polycystic ovary syndrome (PCOS) defines discrete subgroups whose phenotypes are not yet clear.
Objective: The phenotypic characteristics of women in the PCOS subgroups defined by the Rotterdam criteria were compared.
Design: The study was observational.
Setting: Subjects were studied in an outpatient setting in Boston and Reykjavik.
Patients: Four subgroups of subjects with PCOS defined by 1) irregular menses (IM), hyperandrogenism (HA), and polycystic ovary morphology (PCOM, n = 298); 2) IM/HA (n = 7); 3) HA/PCOM (n = 77); and 4) IM/PCOM (n = 36) and a group of controls (n = 64), aged 18–45 yr, were examined.
Intervention: Subjects underwent a physical exam; fasting blood samples for androgens, gonadotropins, and metabolic parameters; and a transvaginal ultrasound.
Main Outcome Measures: The phenotype was compared between groups.
Results: Ninety-seven percent of women with IM/HA had PCOM. Therefore, the groups with and without PCOM were combined. The Ferriman-Gallwey score and androgen levels were highest in the hyperandrogenic groups (IM/HA and HA/PCOM), whereas ovarian volume was higher in all PCOS subgroups compared with controls, as expected based on the definitions of the PCOS subgroups. Body mass index and insulin levels were highest in the IM/HA subgroup.
Conclusions: Subjects with PCOS defined by IM/HA are the most severely affected women on the basis of androgen levels, ovarian volumes, and insulin levels. Their higher body mass index partially accounts for the increased insulin levels, suggesting that weight gain exacerbates the symptoms of PCOS.</abstract><cop>Bethesda, MD</cop><pub>Endocrine Society</pub><pmid>17003085</pmid><doi>10.1210/jc.2006-1327</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-972X |
ispartof | The journal of clinical endocrinology and metabolism, 2006-12, Vol.91 (12), p.4842-4848 |
issn | 0021-972X 1945-7197 |
language | eng |
recordid | cdi_proquest_miscellaneous_68224401 |
source | Oxford Journals Online |
subjects | Adolescent Adult Androgens - blood Biological and medical sciences Body Mass Index Body Weight - physiology Endocrinopathies Female Fundamental and applied biological sciences. Psychology Gonadotropins - blood Hormones - blood Humans Medical sciences Metabolic Syndrome - blood Metabolic Syndrome - epidemiology Metabolism - physiology Middle Aged Phenotype Physical Examination Polycystic Ovary Syndrome - classification Vertebrates: endocrinology |
title | Characterizing Discrete Subsets of Polycystic Ovary Syndrome as Defined by the Rotterdam Criteria: The Impact of Weight on Phenotype and Metabolic Features |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T15%3A16%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterizing%20Discrete%20Subsets%20of%20Polycystic%20Ovary%20Syndrome%20as%20Defined%20by%20the%20Rotterdam%20Criteria:%20The%20Impact%20of%20Weight%20on%20Phenotype%20and%20Metabolic%20Features&rft.jtitle=The%20journal%20of%20clinical%20endocrinology%20and%20metabolism&rft.au=Welt,%20C.%20K.&rft.date=2006-12-01&rft.volume=91&rft.issue=12&rft.spage=4842&rft.epage=4848&rft.pages=4842-4848&rft.issn=0021-972X&rft.eissn=1945-7197&rft.coden=JCEMAZ&rft_id=info:doi/10.1210/jc.2006-1327&rft_dat=%3Cproquest_cross%3E68224401%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c401t-e3d25736b2baf9660ae8761fd06ce2260d155757677a63ca481c75df217200fa3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68224401&rft_id=info:pmid/17003085&rfr_iscdi=true |